India’s pharmaceutical manufacturing ecosystem has evolved into one of the most trusted and competitive in the world. Over the last decade, Contract Development and Manufacturing Organisations (CDMOs) in India have...
Read MoreTheon Lifesciences Ltd. is among India’s leading sterile injectable manufacturers, built to meet the standards of the world’s most regulated markets. Operating from a 4,55,000 sq. ft. USFDA, WHO-GMP, and ISO-certified facility, we ensure precision, scalability, and compliance at every step, from high-speed automated lines to NABL-accredited labs and intelligent data systems.
With a strong foothold in pharma formulations, We are rapidly growing as a trusted global partner, delivering affordable and innovative injectable therapies across Europe, the USA, Latin America, South Africa, and Australia.
Our mission: To make world-class injectable solutions accessible through quality, efficiency, and trust.
Our dedicated production lines for sterile injectable includes:
We Undertake The Technology Transfer For Liquid vials, Ampoules, PFS and Ophthalmic Generic Formulations.
All lines are qualified and ready for media fill in this month of May 2025.
Automatic Ampoule loading, washing machine, tunnel filling and sealing machine is qualified along with terminal sterilizer, labelling machine and Blister machine and complete Ampoule line set up is ready for operations.
Ophthalmic Filling and sealing Machine ROMACO (3 piece) is qualified and ready for operations
Aseptic Process Simulation Activity is Scheduled in May 2025 and is under process.
Our all areas of four lines: vial, ampoules, PFS, and Ophthalmic are Qualified for continuous sterile manufacturing.
Complete vial line starting from loading of vials, washing, 04 tunnel, filling and sealing is qualified along with Automatic Loading and un-loading system for Lyophilizer and lyophilizer is qualified and ready operations.
PFS Filling Machine is Under Qualification.
Manufacturing Vessel System Compounding and Holding 08 vessels are qualified for all four lines and ready for operations.
Media Fill activities will Be Completed in June 2025 Before Starting the Commercial Production.
We are a dedicated hub for formulation development and innovative sterile injectables, focused on driving global market readiness. Our expertise spans complex generics, novel delivery systems, and seamless technology transfer support.
We are specialized in manufacturing liquid vials, ampoules, lyophilized injectables, pre-filled syringes, and ophthalmic preparations. Our advanced technology transfer capabilities ensure regulatory compliance, and faster market entry for complex generics and novel formulations.
With a world-class infrastructure, we can produce high-volume, and reliable production. We can adjust to market demands because of our automation and process optimization, guaranteeing a reliable supply chain for both developing and heavily regulated international markets.
We are committed to build an eco-conscious manufacturing facility as our units are equipped with 100 KLD ETP and 50 KLD STP for wastewater treatment. From waste minimization to responsible sourcing of raw materials, every step reflects our dedication to sustainability.
Facility validated for stringent international regulatory requirements.
From robotic PFS filling to advanced compounding and vessel systems.
Focused on creating value for global partners through reliability and innovation.
21 CFR part 11 compliant systems with real-time monitoring and traceability.

Automated lines capable of handling millions of units annually.
Facility validated for stringent international regulatory requirements.
From robotic PFS filling to advanced compounding and vessel systems.
Automated lines capable of handling millions of units annually.
21 CFR part 11 compliant systems with real-time monitoring and traceability.
Focused on creating value for global partners through reliability and innovation.
Our objective is simple: to develop life-saving medications while also preserving the environment.
Our Globally Recognized Quality Standards and Certifications
Measurable Results Delivered with our Manufacturing Excellence
What our pharmaceutical partners say about us or Insights from Our Global Network

Global Pharma Corp

MedTech Solutions

Global Pharma Corp
Our News & Events section highlights the recognitions, achievements, and global engagements that shape our journey.
A proud day for Theon Pharmaceuticals! We were awarded India’s Top Contract Manufacturing Company of the Year at the Asia Excellence Awards 2025, a hallmark of achievement for us and the acknowledgment of our commitment to quality, innovation, and global healthcare excellence.
We were proud to participate in IPHEX 2025, a premier platform showcasing India’s pharmaceutical innovation to the world. It was an incredible opportunity to engage with industry leaders, explore collaborations, and discuss the future of global healthcare manufacturing.
We were excited to participate in the BRICS CCI Healthcare Summit 2025, where leaders from around the globe came together to discuss the most significant challenges in healthcare. The summit centered around shared innovation, creating trust-based ecosystems, and gaining access to quality medicines.
We had the privilege of visiting the Malaysian High Commission in New Delhi, which reinforced Theon Pharmaceuticals’ goal of purposeful international growth. The discussion centered on three common values: patient-centered growth, sustainability, and healthcare innovation. This created intriguing opportunities for future cross-border cooperation.
Stay updated with the latest news, insights, and blogs featuring industry trends, expert tips, and updates to keep you informed and inspired
India’s pharmaceutical manufacturing ecosystem has evolved into one of the most trusted and competitive in the world. Over the last decade, Contract Development and Manufacturing Organisations (CDMOs) in India have...
Read MoreA sterile injectable facility is held to the highest global standards. Every batch, every vial, and every process step is guided by strict regulatory expectations. The foundation of this ecosystem...
Read MoreThe increased demand for advanced biologics and biosimilars in 2025 will influence the growing demand for sterile injectable manufacturing, as a result of customized medicine and the treatment of chronic...
Read MoreLet’s discuss how Theon Lifesciences can support your pharmaceutical manufacturing needs with ethical innovation and global compliance.